Intranasal triamcinolone and growth velocity

Pediatrics

Volumn 135, Issue 2, 2015, Pages e348-e356

  Skoner, David P ^a,b   Berger, William E ^c   Gawchik, Sandra M ^d,e   Akbary, Akbar ^f   Qiu, Chunfu ^f  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Asthma and Allergy Research Associates   (United States)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HYDROCORTISONE; PLACEBO; TRIAMCINOLONE ACETONIDE;

ARTICLE; BODY HEIGHT; BODY MASS; BONE AGE; CAUCASIAN; CHILD; CHILD GROWTH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; ETHNICITY; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PERENNIAL RHINITIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; UNITED STATES; UNSPECIFIED SIDE EFFECT; VITAL SIGN; CLINICAL TRIAL; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; REGRESSION ANALYSIS; RHINITIS, ALLERGIC, PERENNIAL; URINE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEAST-SQUARES ANALYSIS; MALE; PITUITARY-ADRENAL SYSTEM; RHINITIS, ALLERGIC, PERENNIAL; TRIAMCINOLONE ACETONIDE;

EID: 84922614921     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-1641     Document Type: Article

References (33)

1. Nasser M, Fedorowicz Z, Aljufairi H, McKerrow W. Antihistamines used in addition to topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev. 2010;(7):CD006989
2. Small P, Kim H. Allergic rhinitis. Allergy Asthma Clin Immunol. 2011;7(suppl 1):S3-S10
3. Gentile D, Bartholow A, Valovirta E, Scadding G, Skoner D. Current and future directions in pediatric allergic rhinitis. J Allergy Clin Immunol Pract. 2013;1(3):214-226; quiz 227
4. Wallace DV, Dykewicz MS, Bernstein DI, et al; Joint Task Force on Practice; American Academy of Allergy,; Asthma & Immunology; American College of Allergy,; Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 suppl):S1-S84
5. Brozek JL, Bousquet J, Baena-Cagnani CE, et al; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476
6. Turner PJ, Kemp AS. Allergic rhinitis in children. J Paediatr Child Health. 2012;48(4):302-310
7. Nasacort AQ [package insert]. Bridgewater, NJ: Sanofi-aventis US LLC; 2008. Available at: http://products.sanofi.us/Nasacort-AQ/nasacort-aq.html. Accessed October 3, 2013
8. US Food and Drug Administration. Guidance for industry - orally inhaled and intranasal corticosteroids: evaluation of the effects on growth in children. Rockville, MD: US Department of Health and Human Services, Center for Drug Evaluation and Research; 2007. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071968.pdf. Accessed October 3, 2013
9. Bartholow AK, Deshaies DM, Skoner JM, Skoner DP. A critical review of the effects of inhaled corticosteroids on growth. Allergy Asthma Proc. 2013;34(5):391-407
10. Skoner DP, Maspero J, Banerji D; Ciclesonide Pediatric Growth Study Group. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics. 2008;121(1). Available at: www.pediatrics.org/cgi/content/full/121/1/e1
11. Becker AB, Kuznetsova O, Vermeulen J, et al; Pediatric Montelukast Linear Growth Study Group. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann Allergy Asthma Immunol. 2006;96(6):800-807
12. Weinstein S, Qaqundah P, Georges G, Nayak A. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol. 2009;102(4):339-347
13. Skoner DP, Gentile DA, Doyle WJ. Effect on growth of long-term treatment with intranasal triamcinolone acetonide aqueous in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2008;101(4):431-436
14. Skoner DP, Gentile D, Angelini B, Kane R, Birdsall D, Banerji D. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2003;90(1):56-62
15. Allen DB, Meltzer EO, Lemanske RF Jr, et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002;23(6):407-413
16. Murphy K, Uryniak T, Simpson B, O'Dowd L. Growth velocity in children with perennial allergic rhinitis treated with budesonide aqueous nasal spray. Ann Allergy Asthma Immunol. 2006;96(5):723-730
17. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000;105(2). Available at: www.pediatrics.org/cgi/content/full/105/2/e22
18. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics. 2000;105(2). Available at: www.pediatrics.org/cgi/content/full/105/2/e23
19. ClinicalTrials.gov. Phase 4 fluticasone furoate nasal spray (VERAMYST) long term pediatric growth study. Available at: http://clinicaltrials.gov/show/NCT00570492. Accessed October 15, 2013
20. Camargos PA, Lasmar LM. Effects of beclomethasone and factors related to asthma on the growth of prepubertal children. Respir Med. 2010;104(7):951-956
21. Pedersen S. Safety aspects of corticosteroids in children. Eur Respir Rev. 1994;4(17):33-43
22. Doull IJ, Campbell MJ, Holgate ST. Duration of growth suppressive effects of regular inhaled corticosteroids. Arch Dis Child. 1998;78(2):172-173
23. Wolthers OD, Pedersen S. Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr. 1993;82(8):635-640
24. Karlberg J, Gelander L, Albertsson-Wikland K. Distinctions between shortand long-term human growth studies. Acta Paediatr. 1993;82(8):631-634
25. Anthracopoulos MB, Papadimitriou A, Panagiotakos DB, et al. Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment. Pediatr Pulmonol. 2007;42(5):465-470
26. Turpeinen M, Nikander K, Pelkonen AS, et al. Daily versus as-needed inhaled corticosteroid for mild persistent asthma (the Helsinki Early Intervention Childhood Asthma Study). Arch Dis Child. 2008;93(8):654-659
27. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985-1997
28. Agertoft L, Pedersen S. Effect of longterm treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000;343(15):1064-1069
29. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials. 1999;20(1):91-120
30. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343(15):1054-1063
31. Kelly HW, Sternberg AL, Lescher R, et al; CAMP Research Group. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med. 2012;367(10):904-912
32. Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol. 2001;51(5):400-409
33. Georges G, Kim KT, Ratner P, Segall N, Qiu C. Effect of intranasal triamcinolone acetonide on basal hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Allergy Asthma Proc. 2014;35(2):163-170